11 – 20 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Determining the Appropriate Risk-Adapted Screening Age for Familial Breast Cancer-Reply
- Contribution to journal › Letter
- 2019
-
Mark
Association of Immune Marker Changes with Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
(2019) In JAMA Oncology
- Contribution to journal › Article
-
Mark
Risk-Adapted Starting Age of Screening for Relatives of Patients with Breast Cancer
(2019) In JAMA Oncology
- Contribution to journal › Article
- 2018
-
Mark
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 : A Systematic Analysis for the Global Burden of Disease Study
- Contribution to journal › Article
-
Mark
Global Burden of Multiple Myeloma : A Systematic Analysis for the Global Burden of Disease Study 2016
- Contribution to journal › Article
-
Mark
Targeted Alpha Therapy, an Emerging Class of Cancer Agents : A Review
- Contribution to journal › Scientific review
-
Mark
Phase 3 assessment of the automated bone scan index as a prognostic imaging biomarker of overall survival in men with metastatic castration-resistant prostate cancer a secondary analysis of a randomized clinical trial
- Contribution to journal › Article
-
Mark
Assessment of Late Mortality Risk after Allogeneic Blood or Marrow Transplantation Performed in Childhood
- Contribution to journal › Article
-
Mark
Association of statin usewith overall and cancer survival
- Contribution to journal › Letter
- 2017
-
Mark
Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib : An exploratory analysis of a randomized clinical trial
- Contribution to journal › Article
